Seasonal Affective Disorder
📧 Sign up to get email alerts when something new happens for Seasonal Affective Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-02-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic Bupropion hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2013-12-23FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) by GlaxoSmithKline LLC.
-
FDA approval · 2013-08-16FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc., approving an added or amended aspect o…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Transcranial Bright Light Therapy in Seasonal Affective Disorder (SAD) [NA]
The document notes that a clinical trial evaluating transcranial bright light therapy for Seasonal Affective Disorder has completed.
-
FDA approval · 2013-03-19FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) from GlaxoSmithKline LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD) [Phase 2, Phase 3]
A Phase 2/3 randomized trial comparing negative ion generation to LED phototherapy for Seasonal Affective Disorder has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Environmental Treatment for Seasonal Affective Disorder (SAD) [NA]
This is an update on a completed clinical trial at Yale investigating environmental treatment for Seasonal Affective Disorder, with results …
-
FDA approval · 2012-08-02FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2012-04-23FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for Bupropion HCl sustained-release (Actavis), finalizing changes to the approved generic product.
-
FDA approval · 2012-04-18FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff [Phase 4]
Phase 4 trial assessing whether vitamin D3 supplementation improves well-being and reduces depressive symptoms during winter among health se…
-
FDA approval · 2012-03-28FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Bupropion Hydrochloride from Apnar Pharma LP, confirming approval of a generic formulation.
-
FDA approval · 2012-03-27FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, granting approval for a generic product under an A…
-
FDA approval · 2012-02-21FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for bupropion hydrochloride (generic), confirming approval fo…
-
FDA approval · 2011-11-10FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved bupropion hydrochloride from Upsher-Smith Laboratories in an original application, authorizing its use for major depressive dis…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Low Intensity 'Blue Light' Treatment of Seasonal Affective Disorder [NA]
A completed clinical trial evaluated low-intensity blue light treatment for Seasonal Affective Disorder.
-
FDA approval · 2011-08-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for bupropion hydrochloride from Aurobindo Pharma Limited, allowing the generic product to be market…
-
FDA approval · 2011-07-26FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) from Bausch Health US LLC.
-
FDA approval · 2011-07-26FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC. This action updates the product la…
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: Bright Light Therapy in Seasonal Affective Disorder (SAD) [NA]
Clinical trial evaluating bright light therapy for Seasonal Affective Disorder has completed.
-
FDA approval · 2011-01-21FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for bupropion hydrochloride from BluePoint Laboratories, approving changes to an existing generic pr…
-
FDA approval · 2010-08-30FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL (Actavis), a generic extended-release formulation of bupropion hydroc…
-
FDA approval · 2010-07-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, approving changes associated with this generic pro…
-
FDA approval · 2010-07-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves BluePoint Laboratories' supplemental application for Bupropion Hydrochloride under ANDA 076143, approving changes to the approv…
-
FDA approval · 2010-06-25FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride from Actavis Pharma, Inc., bringing this generic product under the appro…